Biostax Corp.
BTAX
$0.01
$0.00111.11%
Weiss Ratings | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Very Weak | |||
Risk Grade | E+ | |||
Reward Grade | E | |||
Rating Factors | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Very Weak | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 2.24 | |||
Price History | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | -47.37% | |||
90-Day Total Return | -71.43% | |||
Year to Date Total Return | -37.11% | |||
1-Year Total Return | -80.58% | |||
2-Year Total Return | -98.61% | |||
3-Year Total Return | -99.39% | |||
5-Year Total Return | -99.84% | |||
52-Week High % Change | -93.33% | |||
52-Week Low % Change | 104.08% | |||
Price | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.15 | |||
52-Week Low Price | $0.00 | |||
52-Week Low Price (Date) | Jan 02, 2025 | |||
52-Week High Price (Date) | Aug 21, 2024 | |||
Valuation | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 787.14K | |||
Enterprise Value | 1.96M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.03 | |||
Earnings Per Share Growth | -48.18% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -0.16 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $0.01 | |||
Enterprise Value/EBITDA (TTM) | -1.69 | |||
Enterprise Value/EBIT | -1.62 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 83.70M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 888 391 9355 | |||
Address | 1317 Edgewater Dr. Orlando, FL 32804 | |||
Website | www.biostaxcorp.com | |||
Country | United States | |||
Year Founded | -- | |||
Profitability | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -198.07% | |||
Return on Equity | -- | |||
Income Statement | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -1.16M | |||
EBIT (TTM) | -1.21M | |||
Net Income (TTM) | -2.21M | |||
Net Income Avl. to Common (TTM) | -2.21M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | 15.11% | |||
EPS Diluted (TTM) | -0.03 | |||
EPS Diluted Growth (Q YOY) | 0.00% | |||
Balance Sheet | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 0.00 | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 0.00 | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -5.30M | |||
Current Ratio (Q) | 0.000 | |||
Book Value Per Share (Q) | -$0.06 | |||
Total Assets (Q) | 5.50K | |||
Total Current Liabilities (Q) | 5.31M | |||
Total Debt (Q) | 1.17M | |||
Total Liabilities (Q) | 5.31M | |||
Total Common Equity (Q) | -5.30M | |||
Cash Flow | BTAX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -153.50K | |||
Net Change in Cash (TTM) | -17.40K | |||
Levered Free Cash Flow (TTM) | 555.70K | |||
Cash from Operations (TTM) | 136.10K | |||